Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/12/2012 | CN102813031A Lipid-lowering and liver-protecting herbal tea |
12/12/2012 | CN102382199B High yield energy saving preparation method of Hericium erinaceus polysaccharide |
12/12/2012 | CN102274464B Chinese medicinal composition for treating chronic hepatitis, splenauxe and cirrhosis |
12/12/2012 | CN102274194B Pharmaceutical composition containing tropisetron compound and preparation method thereof |
12/12/2012 | CN102240286B Application of matrine to medicament for treating or preventing enterovirus 71 type infection |
12/12/2012 | CN102191147B Cornus officinalis fruit wine and preparation method thereof |
12/12/2012 | CN102188647B Chinese medicinal composition for treating ulcer and inflammation of digestive systems and preparation method thereof |
12/12/2012 | CN102140460B SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
12/12/2012 | CN102139017B Raw materials of kidney tonifying spirits, kidney tonifying spirits and preparation method of kidney tonifying spirits |
12/12/2012 | CN102100818B Quality control method for lophanthus antifebrile tablets |
12/12/2012 | CN102068418B Sofalcone sustained-release pellet capsule preparation and preparation method thereof |
12/12/2012 | CN102048747B Tulathromycin composition used for treating or preventing pet bacterial diseases and preparation method thereof |
12/12/2012 | CN102000225B Health care medicament for sobering, removing alcoholism and preventing and treating fatty liver and preparation method thereof |
12/12/2012 | CN101875648B Method for extracting and purifying Pinostrobin from medicinal plants, and pharmaceutical preparation and application thereof |
12/12/2012 | CN101791384B Chinese patent medicine for treating infantile malnutrition of infants |
12/12/2012 | CN101757641B Preparation technique of cardamom volatile oil inclusion complex |
12/12/2012 | CN101643432B New process for obtaining the crystalline form v of agomelatine |
12/12/2012 | CN101584793B Pure natural health-care four-Huai medicine |
12/12/2012 | CN101524363B Artificial saliva |
12/12/2012 | CN101507735B Oyster calcining technological process |
12/12/2012 | CN101486677B 5HT2C receptor modulators |
12/12/2012 | CN101214336B Pure natural Chinese herbal medicine for treating gastroenteritis |
12/11/2012 | US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use |
12/11/2012 | US8329742 Macrocyclic compounds useful as pharmaceuticals |
12/11/2012 | US8329687 Pyridooxazepine derivative and use thereof |
12/11/2012 | US8329662 Prodrug of an ICE inhibitor |
12/11/2012 | US8329661 Method for using HIP/PAP polypeptide composition for liver regeneration and prevention of liver failure |
12/11/2012 | US8329658 Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection |
12/11/2012 | US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
12/11/2012 | US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
12/11/2012 | CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
12/11/2012 | CA2411563C Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
12/06/2012 | WO2012167109A2 Rpgrip1 gene therapy for leber congenital amaurosis |
12/06/2012 | WO2012165736A1 Remedy for gastritis and gastric ulcer |
12/06/2012 | WO2012165398A1 Cycloalkyloxybiaryl compound |
12/06/2012 | WO2012164473A1 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
12/06/2012 | WO2012163848A1 Methods and pharmaceutical compositions for the treatment of crohn's disease |
12/06/2012 | WO2012163289A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof |
12/06/2012 | WO2012163174A1 Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative thereof |
12/06/2012 | WO2012162777A1 Oral pharmaceutical composition comprising a proton pump inhibitor and a prokinetic agent that can be used in excess stomach acid disorders |
12/06/2012 | US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
12/06/2012 | US20120309848 Novel uses of nonenal |
12/06/2012 | US20120309836 Methods and compositions for administration of trpv1 agonists |
12/06/2012 | US20120309834 Novel uses of adipic acid |
12/06/2012 | US20120309833 Novel bexarotene analogs |
12/06/2012 | US20120309822 Treatment of infectious diseases |
12/06/2012 | US20120309820 Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids |
12/06/2012 | US20120309814 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
12/06/2012 | US20120309800 Metalloenzyme inhibitor compounds |
12/06/2012 | US20120309795 Heterocyclic inhibitors of necroptosis |
12/06/2012 | US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators |
12/06/2012 | US20120309786 3-amino-pyridine derivatives for the treatment of metabolic disorders |
12/06/2012 | US20120309784 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases |
12/06/2012 | US20120309758 Modulators of atp-binding cassette transporters |
12/06/2012 | US20120309747 Protein kinase inhibitors |
12/06/2012 | US20120309746 Triazolopyridine compounds |
12/06/2012 | US20120309730 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling |
12/06/2012 | US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives |
12/06/2012 | US20120309715 Use of Simethicone in Constipated Patients |
12/06/2012 | US20120309712 Compositions Comprising Dietary Fat Complexer and Methods for Their Use |
12/06/2012 | US20120309699 Compounds having anti-inflammatory activity |
12/06/2012 | US20120309697 Methods of diagnosing and prognosing colonic polyps |
12/06/2012 | US20120309695 Crystalline form of linaclotide |
12/06/2012 | US20120309685 Purified emd protein composition |
12/06/2012 | US20120309683 USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
12/06/2012 | US20120309678 Treatment of Inflammatory Bowel Diseases With Mammal Beta Defensins |
12/06/2012 | US20120309672 Treatment of extracellular matrix to reduce inflammation |
12/06/2012 | US20120308661 Orally administrable pharmaceutical pellet of epidermal growth factor |
12/06/2012 | US20120308659 Pellet formulation for the treatment of the intenstinal tract |
12/06/2012 | US20120308622 Compositions of Apatite and Methods of Use |
12/06/2012 | US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels |
12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
12/06/2012 | US20120308588 Neprilysin inhibitors |
12/06/2012 | US20120308585 Methods and compositions for use in cellular therapies |
12/06/2012 | US20120308581 Compositions and methods for detecting tlr3 |
12/06/2012 | US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
12/06/2012 | US20120308573 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
12/06/2012 | US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells |
12/06/2012 | US20120308553 Oral medication for the treatment of hemorrhoids and method of use |
12/06/2012 | US20120308545 Crystallized Oxalate Decarboxylase and Methods of Use |
12/06/2012 | US20120308543 Lipase Variants for Pharmaceutical Use |
12/06/2012 | US20120308541 Pharmaceutical composition for treating the gastrointestinal tract |
12/06/2012 | US20120308539 Lactic acid bacteria having action of lowering blood uric acid level |
12/06/2012 | US20120308536 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
12/06/2012 | US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment |
12/06/2012 | US20120308523 Method for Reducing Gastro-Intestinal Inflammation Using Bifidobacterium Animalis Bacteria or a Fermented Dairy Product Comprising Such Bacteria |
12/06/2012 | US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
12/06/2012 | US20120308514 Human antibodies that bind human il-12 and methods for producing |
12/06/2012 | US20120308483 Treatment of Sleep Disturbances |
12/06/2012 | US20120308480 Humanized antibodies against tl1a |
12/06/2012 | CA2835916A1 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
12/05/2012 | EP2529743A1 Prophylactic or therapeutic agent for crohn's disease comprising organic acid polymer as active ingredient |
12/05/2012 | EP2529739A1 Therapeutic or prophylactic agent for biliary diseases |
12/05/2012 | EP2528610A1 Probiotic composition for use in the treatment of bowel inflammation |
12/05/2012 | EP2528605A1 Therapies for treating hepatitis c virus infection |
12/05/2012 | EP2528595A1 Compounds for use in the treatment of diseases |
12/05/2012 | CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same |
12/05/2012 | CN102812028A Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
12/05/2012 | CN102812027A Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
12/05/2012 | CN102807942A Preparation method for morchella wine |